i-STAT presses for costs after Nova patent case fails:
This article was originally published in Clinica
Executive Summary
Attacking rival company Nova Biomedical's 1995 patent suit against it as a competitive ploy, rather then based on a genuine belief that i-STAT had infringed its patent, i-STAT is demanding costs against the company following a judgement against Nova in a Massachusetts district court. Both companies manufacture point-of-care analysers.